23 Feb 2018 | 8:19 PM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
38.80
0.56
(1.44 %)
23 Feb 2018 | 03:47 PM
Change company
  • Open (Rs)
    38.10
  • Prev. close (Rs.)
    38.25
  • High (Rs.)
    39.21
  • Low (Rs.)
    38.10
  • 52W H (Rs.)
    58.25
  • 52W L (Rs.)
    34.25
  • Volume
    429249
  • MCap (Rs in Cr.)
    1,588.14
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
0.23
Operating Margin (%)
5.79
Gross Profit Margin (%)
1.87
Net Profit Margin (%)
1.24
Total Debt/Equity
0.25
Dividend payout Ratio (Net Profit)
152.64
Earning Retention Ratio
-20.93

News

13 Nov 2017 - 12:57:00-The company reported standalone net profit of Rs 1...
09 Oct 2017 - 15:57:00-Drug firm Marksans Pharma today said it has received Establishment Inspection Report (EIR) from the ...
11 Aug 2017 - 14:57:00-The company reported standalone net profit of Rs 1...
11 Aug 2017 - 14:57:00-The company reported standalone net profit of Rs 1...

Announcements

12-Feb-2018
Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
12-Feb-2018
Marksans Pharma - Announcement under Regulation 30 (LODR)-Updates
12-Feb-2018
Marksans Pharma - Board Meeting-Outcome of Board Meeting
12-Feb-2018
Marksans Pharma - Financial Result Updates
12-Feb-2018
Marksans Pharma - Outcome of Board Meeting

Religare Research

23 Feb 2018 | 06:00 PM
The power transmission sector outlook remains bright with huge energy demand in India, increasing in...
23 Feb 2018 | 06:00 PM
The benchmark index, Nifty traded volatile and consolidated in a range as participants preferred to ...
23 Feb 2018 | 03:14 PM
Nifty futures has rolled around 62% vs 66% with respect to last month, and the open interest for the...
23 Feb 2018 | 12:40 PM
Highlights: Prospects of rains in parts of MP, Maharashtra, North-West and North India during w...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 26.60 -0.45
6,68,725 6.05 38.91 -0.45
6,68,725 6.05 41.24 -0.45
6,68,725 6.05 30.17 -0.44

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks2.79%
Insurance2.79%
FII2.34%
Government0.00%
Others9.14%

Peer Group

Company Intraday Graph
 DIL Ltd.
3,321.45(1.18)
3299
 Hester Biosciences Ltd.
1,580.00(0.14)
3572
 Merck Ltd.
1,485.95(2.91)
3302
 Kovai Medical Center and Hospital Ltd.
1,300.00(0.02)
11816

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.-5.20-2.301.65
NIFTY(S&P CNX)-475.15148.75725.50
BSE SENSEX-1,655.86580.602,850.30
BSE 500-843.4689.821,188.29

Corporate Details

Key Personal
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Vinay Gopal Nayak
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

info@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :1st Floor Bharat Tin Works Building Opp. Vasant Oasis Makwana Road Marol Andheri (East)